Log in to save to my catalogue

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblast...

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblast...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ab21691b67f4af6a88731fc02b3c2eb

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

About this item

Full title

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-05, Vol.12 (1), p.2582-16, Article 2582

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immune checkpoint blockers (ICBs) have failed in all phase III glioblastoma (GBM) trials. Here, we show that regulatory T (Treg) cells play a key role in GBM resistance to ICBs in experimental gliomas. Targeting glucocorticoid-induced TNFR-related receptor (GITR) in Treg cells using an agonistic antibody (αGITR) promotes CD4 Treg cell differentiati...

Alternative Titles

Full title

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1ab21691b67f4af6a88731fc02b3c2eb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ab21691b67f4af6a88731fc02b3c2eb

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-22885-8

How to access this item